Breakdown | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.86B | 1.94B | 2.14B | 1.23B | 1.08B |
Gross Profit | 1.35B | 1.21B | 1.33B | 638.60M | 521.20M |
EBITDA | 117.90M | 284.20M | 172.50M | 174.10M | 195.60M |
Net Income | -185.30M | 8.20M | 36.80M | -142.60M | 56.90M |
Balance Sheet | |||||
Total Assets | 3.59B | 5.00B | 5.51B | 5.76B | 4.51B |
Cash, Cash Equivalents and Short-Term Investments | 486.50M | 505.60M | 1.58B | 1.79B | 1.30B |
Total Debt | 917.50M | 937.40M | 992.40M | 762.60M | 572.30M |
Total Liabilities | 1.54B | 2.67B | 3.11B | 3.26B | 2.78B |
Stockholders Equity | 2.04B | 2.33B | 2.40B | 2.49B | 1.74B |
Cash Flow | |||||
Free Cash Flow | -54.50M | 4.20M | -62.40M | 117.90M | 93.40M |
Operating Cash Flow | -53.30M | 23.70M | -15.20M | 134.30M | 114.70M |
Investing Cash Flow | 175.60M | 128.30M | -73.70M | -742.70M | 254.50M |
Financing Cash Flow | -192.10M | -149.80M | -51.00M | 902.80M | -106.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
67 Neutral | $17.02B | 11.60 | 9.79% | 3.95% | 10.61% | 2.06% | |
61 Neutral | AU$3.01B | ― | -7.21% | 2.07% | -8.26% | -259.91% | |
― | $2.70B | 28.91 | 4.84% | 1.84% | ― | ― | |
― | €1.01B | 7.44 | 23.27% | ― | ― | ― | |
― | €1.36B | ― | -24.47% | ― | ― | ― | |
71 Outperform | AU$1.57B | 21.50 | 4.97% | 6.76% | 13.48% | -8.15% | |
50 Neutral | AU$1.36B | 29.90 | 10.26% | 2.50% | 31.89% | 45.79% |
Insignia Financial Ltd has announced it will release its financial results for the year ending June 30, 2025, on August 21, 2025. Following the results announcement, a webcast and teleconference will be held by CEO Scott Hartley and CFO David Chalmers to discuss the results and answer questions, indicating a transparent approach to stakeholder communication.
The most recent analyst rating on (AU:IFL) stock is a Sell with a A$2.21 price target. To see the full list of analyst forecasts on Insignia Financial Ltd stock, see the AU:IFL Stock Forecast page.
Insignia Financial Ltd has announced a change in its substantial holding in Argenica Therapeutics Limited, indicating a shift in its investment strategy. The company has ceased to be a substantial holder as of July 16, 2025, following a series of transactions involving purchases and sales of shares through its subsidiaries, IOOF Investment Services Ltd and MLC Investments Ltd. This change may impact Insignia Financial’s market positioning and influence its stakeholders’ perceptions regarding its investment focus and strategy.
The most recent analyst rating on (AU:IFL) stock is a Sell with a A$2.21 price target. To see the full list of analyst forecasts on Insignia Financial Ltd stock, see the AU:IFL Stock Forecast page.
Insignia Financial Ltd has announced a change in the interests of a substantial holder, with State Street Corporation and its subsidiaries, including State Street Global Advisors and State Street Bank and Trust Company, holding significant voting power. This change in voting power reflects a strategic adjustment in the company’s shareholder structure, potentially impacting its governance and decision-making processes.
The most recent analyst rating on (AU:IFL) stock is a Sell with a A$2.21 price target. To see the full list of analyst forecasts on Insignia Financial Ltd stock, see the AU:IFL Stock Forecast page.
Insignia Financial Ltd reported a significant increase in Funds Under Management and Administration (FUMA) by $8.5 billion, reaching $330.3 billion as of June 30, 2025. The company achieved record net inflows in its MLC Expand platform and successfully transitioned Master Trust functions to SS&C, strengthening its operational efficiency. Additionally, Insignia announced a new partnership with TAL and Challenger to launch an innovative retirement income solution, MLC Retirement Boost, and entered into a scheme with CC Capital for a potential acquisition. These developments are expected to enhance Insignia’s market positioning and offer growth opportunities in the upcoming fiscal year.
The most recent analyst rating on (AU:IFL) stock is a Sell with a A$2.21 price target. To see the full list of analyst forecasts on Insignia Financial Ltd stock, see the AU:IFL Stock Forecast page.
Insignia Financial Ltd has entered into a Scheme Implementation Deed with CC Capital, under which CC Capital will acquire all issued shares of Insignia Financial for $4.80 per share, representing a significant premium over previous share prices. The board recommends shareholders vote in favor of the scheme, which is subject to various regulatory and shareholder approvals, and is expected to be implemented in the first half of 2026. This acquisition reflects the company’s strategic vision and offers shareholders a substantial cash value, amidst market volatility.
The most recent analyst rating on (AU:IFL) stock is a Sell with a A$2.21 price target. To see the full list of analyst forecasts on Insignia Financial Ltd stock, see the AU:IFL Stock Forecast page.
Insignia Financial Ltd is currently in discussions with CC Capital Partners regarding a non-binding proposal to acquire all of its shares through a scheme of arrangement. While these discussions are ongoing, there is no certainty that they will lead to a transaction for shareholders to consider. Insignia Financial has committed to keeping the market informed in line with its disclosure obligations.
The most recent analyst rating on (AU:IFL) stock is a Sell with a A$2.21 price target. To see the full list of analyst forecasts on Insignia Financial Ltd stock, see the AU:IFL Stock Forecast page.
Insignia Financial Ltd has announced that CC Capital Partners is actively working towards making a binding bid to acquire all shares of Insignia Financial through a scheme of arrangement. While CC Capital is finalizing financing and investment committee approvals, there is no certainty that these discussions will lead to a transaction for shareholders’ consideration. Insignia Financial remains committed to keeping the market informed as per its disclosure obligations.
The most recent analyst rating on (AU:IFL) stock is a Sell with a A$2.21 price target. To see the full list of analyst forecasts on Insignia Financial Ltd stock, see the AU:IFL Stock Forecast page.
Insignia Financial Ltd has experienced a change in the interests of its substantial holder, Australian Retirement Trust Pty Ltd. The voting power of the substantial holder has increased from 10.404% to 11.443%, indicating a significant rise in their stake in the company. This change in voting power could potentially impact the company’s decision-making processes and influence its strategic direction.
The most recent analyst rating on (AU:IFL) stock is a Sell with a A$2.21 price target. To see the full list of analyst forecasts on Insignia Financial Ltd stock, see the AU:IFL Stock Forecast page.
Insignia Financial Ltd has issued a notice under the Corporations Act 2001 regarding its aggregated percentage of voting shares. The notice reveals a slight decrease in the percentage of voting shares controlled by its associated entities, from 0.933% to 0.926%. This announcement may impact the company’s governance and decision-making processes, as it reflects changes in the control over voting shares.
The most recent analyst rating on (AU:IFL) stock is a Sell with a A$2.21 price target. To see the full list of analyst forecasts on Insignia Financial Ltd stock, see the AU:IFL Stock Forecast page.
Insignia Financial Ltd has announced a change in its substantial holding in IDP Education Limited as of June 5, 2025. The notice details various transactions by its subsidiaries, including significant purchases and sales of shares, reflecting strategic adjustments in its investment portfolio. This change may impact Insignia’s market positioning and influence its stakeholders’ interests.
The most recent analyst rating on (AU:IFL) stock is a Sell with a A$2.21 price target. To see the full list of analyst forecasts on Insignia Financial Ltd stock, see the AU:IFL Stock Forecast page.
Insignia Financial Ltd has announced a change in its substantial holding in Botanix Pharmaceuticals Ltd, reflecting a decrease in its voting power from 9.32% to 8.29%. This change is due to a series of market transactions involving purchases and sales of shares by its subsidiaries, IOOF Investment Management Ltd, IOOF Investment Services Ltd, and MLC Investments Ltd. The adjustment in Insignia’s stake could impact its influence within Botanix Pharmaceuticals, potentially affecting strategic decisions and stakeholder interests.